US 11642375
Intracellular genomic transplant and methods of therapy
granted A61KA61K2239/38A61K40/11
Quick answer
US patent 11642375 (Intracellular genomic transplant and methods of therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2239/38, A61K40/11, A61K40/22, A61K40/32